Showing results (151-160 of 172) with videos related to

Sort By:
Pageof 18
Nature|August 29, 1991
Requirement for mast cell growth factor for primordial germ cell survival in cultureS Dolci, D E Williams, M K Ernst, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 16, 2024
Similar metabolic pathways are affected in both Congenital Myasthenic Syndrome-22 and Prader-Willi SyndromeKritika Bhalla, Karen Rosier, Yenthe Monnens, et al.
Radiology|July 16, 1999
Bicipitoradial bursitis: MR imaging findings in eight patients and anatomic data from contrast material opacification of bursae followed by routine radiography and MR imaging in cadaversA Y Skaf, R D Boutin, R W Dantas, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1993
U-90152, a potent inhibitor of human immunodeficiency virus type 1 replicationT J Dueweke, S M Poppe, D L Romero, et al.
Clinical and Translational Science|October 17, 2013
Differential gene expression reveals mitochondrial dysfunction in an imprinting center deletion mouse model of Prader-Willi syndromePuya G Yazdi, Hailing Su, Svetlana Ghimbovschi, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1991
Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replicationD L Romero, M Busso, C K Tan, et al.
The New England Journal of Medicine|December 12, 1985
Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndromeD D Ho, T R Rota, R T Schooley, et al.
Journal of Acquired Immune Deficiency Syndromes|February 1, 1994
The safety and efficacy of combination N-butyl-deoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1 infection and 200-500 CD4 cells/mm3M A Fischl, L Resnick, R Coombs, et al.
Antiviral Research|April 25, 2000
Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: dosage requirements and pharmacokinetic studies. The ACTG 187 and 199 study teamsG D Morse, R C Reichman, M A Fischl, et al.
Experimental Animals|March 25, 2025
A novel early onset spinocerebellar ataxia 13 BAC mouse model with cerebellar atrophy, tremor, and ataxic gaitJunxiang Yin, Jerelyn A Nick, Swati Khare, et al.
Pageof 18